Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial
一项针对50岁及以上成年人带状疱疹的重组gE-Fc融合蛋白亚单位疫苗的免疫原性和安全性随机、阳性对照、非劣效性试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-62800-z
Jin, Peng-Fei; Quan, Ya-Ru; Xiu, Shi-Xin; Jiang, Xian-Min; Pan, Hong-Xing; Shen, Yuan; Wang, Xu-Wen; Kong, Jian; Wang, Wen-Juan; Cao, Xiang; Xu, Kang-Wei; Yang, Min; Yang, Kun; Wan, Wen-Yan; Wang, Kai-Qin; Chen, Li; Yao, Ai-Hua; Xue, Yu-Peng; Wan, Na; Xu, Ming; Tao, Shi-Yao; Peng, Ling; Yan, Fang-Rong; Li, Chang-Gui; Li, Jing-Xin
